STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
90 hedge funds and large institutions have $337M invested in Stemline Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
94% less call options, than puts
Call options by funds: $254K | Put options by funds: $4.08M
Holders
90
Holding in Top 10
2
Calls
$254K
Puts
$4.08M
Top Buyers
| 1 | +$4.18M | |
| 2 | +$2.35M | |
| 3 | +$1.94M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.33M |
Top Sellers
| 1 | -$7.47M | |
| 2 | -$7.3M | |
| 3 | -$2.41M | |
| 4 |
Two Sigma Investments
New York
|
-$2.05M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.52M |